These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7840594)

  • 21. Analysis of the mechanism of quinolone resistance in nalidixic acid-resistant clinical isolates of Salmonella serotype Typhimurium.
    Ruiz J; Castro D; Goñi P; Santamaria JA; Borrego JJ; Vila J
    J Med Microbiol; 1997 Jul; 46(7):623-8. PubMed ID: 9236748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli.
    Yoshida H; Bogaki M; Nakamura M; Nakamura S
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1271-2. PubMed ID: 2168148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cloning and nucleotide sequence of the Campylobacter jejuni gyrA gene and characterization of quinolone resistance mutations.
    Wang Y; Huang WM; Taylor DE
    Antimicrob Agents Chemother; 1993 Mar; 37(3):457-63. PubMed ID: 8384814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequence of quinolone resistance-determining region of gyrA gene for clinical isolates and for an in vitro-selected quinolone-resistant strain of Coxiella burnetii.
    Musso D; Drancourt M; Osscini S; Raoult D
    Antimicrob Agents Chemother; 1996 Apr; 40(4):870-3. PubMed ID: 8849242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alterations in the GyrA subunit of DNA gyrase and the ParC subunit of DNA topoisomerase IV associated with quinolone resistance in Enterococcus faecalis.
    Kanematsu E; Deguchi T; Yasuda M; Kawamura T; Nishino Y; Kawada Y
    Antimicrob Agents Chemother; 1998 Feb; 42(2):433-5. PubMed ID: 9527801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of 4-quinolone resistance in quinolone-resistant and methicillin-resistant Staphylococcus aureus isolates from Japan and China.
    Tanaka M; Zhang YX; Ishida H; Akasaka T; Sato K; Hayakawa I
    J Med Microbiol; 1995 Mar; 42(3):214-9. PubMed ID: 7884804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a primary target of fluoroquinolones.
    Ferrero L; Cameron B; Manse B; Lagneaux D; Crouzet J; Famechon A; Blanche F
    Mol Microbiol; 1994 Aug; 13(4):641-53. PubMed ID: 7997176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of Mycoplasma hominis mutations involved in resistance to fluoroquinolones.
    Bebear CM; Bové JM; Bebear C; Renaudin J
    Antimicrob Agents Chemother; 1997 Feb; 41(2):269-73. PubMed ID: 9021178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of an efflux system in high-level fluoroquinolone resistance of Shigella dysenteriae.
    Ghosh AS; Ahamed J; Chauhan KK; Kundu M
    Biochem Biophys Res Commun; 1998 Jan; 242(1):54-6. PubMed ID: 9439608
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutations in gyrA gene of quinolone-resistant Salmonella serotypes isolated from humans and animals.
    Griggs DJ; Gensberg K; Piddock LJ
    Antimicrob Agents Chemother; 1996 Apr; 40(4):1009-13. PubMed ID: 8849216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alteration in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in Quinolone-resistant Shigella dysenteriae serotype 1 clinical isolates from Kolkata, India.
    Dutta S; Kawamura Y; Ezaki T; Nair GB; Iida K; Yoshida S
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1660-1. PubMed ID: 15793166
    [No Abstract]   [Full Text] [Related]  

  • 32. Detection of ciprofloxacin resistance mutations in Campylobacter jejuni gyrA by nonradioisotopic single-strand conformation polymorphism and direct DNA sequencing.
    Charvalos E; Peteinaki E; Spyridaki I; Manetas S; Tselentis Y
    J Clin Lab Anal; 1996; 10(3):129-33. PubMed ID: 8731499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. gyrA mutations in high-level fluoroquinolone-resistant clinical isolates of Escherichia coli.
    Conrad S; Oethinger M; Kaifel K; Klotz G; Marre R; Kern WV
    J Antimicrob Chemother; 1996 Sep; 38(3):443-55. PubMed ID: 8889719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Limitations of plasmid complementation test for determination of quinolone resistance due to changes in the gyrase A protein and identification of conditional quinolone resistance locus.
    Soussy CJ; Wolfson JS; Ng EY; Hooper DC
    Antimicrob Agents Chemother; 1993 Dec; 37(12):2588-92. PubMed ID: 8109921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a rapid assay for detecting gyrA mutations in Escherichia coli and determination of incidence of gyrA mutations in clinical strains isolated from patients with complicated urinary tract infections.
    Ozeki S; Deguchi T; Yasuda M; Nakano M; Kawamura T; Nishino Y; Kawada Y
    J Clin Microbiol; 1997 Sep; 35(9):2315-9. PubMed ID: 9276409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutations in topoisomerase IV and DNA gyrase of Staphylococcus aureus: novel pleiotropic effects on quinolone and coumarin activity.
    Fournier B; Hooper DC
    Antimicrob Agents Chemother; 1998 Jan; 42(1):121-8. PubMed ID: 9449271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proportion of DNA gyrase mutants among quinolone-resistant strains of Pseudomonas aeruginosa.
    Yoshida H; Nakamura M; Bogaki M; Nakamura S
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1273-5. PubMed ID: 2168149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluoroquinolone resistance linked to both gyrA and parC mutations in the quinolone resistance-determining region of Shigella dysenteriae type 1.
    Talukder KA; Khajanchi BK; Islam MA; Islam Z; Dutta DK; Rahman M; Watanabe H; Nair GB; Sack DA
    Curr Microbiol; 2006 Feb; 52(2):108-11. PubMed ID: 16450072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of gyrA mutations associated with fluoroquinolone resistance in Campylobacter coli by DNA sequence analysis and MAMA PCR.
    Zirnstein G; Helsel L; Li Y; Swaminathan B; Besser J
    FEMS Microbiol Lett; 2000 Sep; 190(1):1-7. PubMed ID: 10981681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA gyrase mutations in quinolone-resistant clinical isolates of Neisseria gonorrhoeae.
    Deguchi T; Yasuda M; Asano M; Tada K; Iwata H; Komeda H; Ezaki T; Saito I; Kawada Y
    Antimicrob Agents Chemother; 1995 Feb; 39(2):561-3. PubMed ID: 7726535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.